Finance

Lists
Why is ELTP down 2,01%?
Dive Deeper
ELTP:OTCMKTS
Elite Pharmaceuticals, Inc. Common Stock
0,22 $
-2,01%
(-0,0046) 1D
5 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELTP...
Open
0,22 $
High
0,23 $
Low
0,21 $
Mkt. cap
239,92 млн
Avg. vol.
837,00 м.
Volume
1,66 млн
P/E ratio
4,57
52-wk high
0,69 $
52-wk low
0,21 $
EPS
0,05 $
Beta
0,33
Shares outstanding
1,08 млрд
No. of employees
65
Open
0,22 $
High
0,23 $
Low
0,21 $
Mkt. cap
239,92 млн
Avg. vol.
837,00 м.
Volume
1,66 млн
P/E ratio
4,57
52-wk high
0,69 $
52-wk low
0,21 $
EPS
0,05 $
Beta
0,33
Shares outstanding
1,08 млрд
No. of employees
65
News stories
From web sources and news partners
About Elite Pharmaceuticals, Inc. Common Stock
CEO-
Employees65
Founded1997
HeadquartersНорсвэйл, Нью-Джерси, Америка Құрама Штаттары
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
36,32 млн
31,59 млн
40,75 млн
32,36 млн
Cost of goods sold
22,25 млн
18,64 млн
19,98 млн
18,85 млн
Cost of revenue
22,25 млн
18,64 млн
19,98 млн
18,85 млн
Research and development expenses
1,39 млн
1,04 млн
1,64 млн
2,03 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,03 млн
2,47 млн
7,70 млн
3,55 млн
Operating expense
5,86 млн
3,94 млн
9,74 млн
5,98 млн
Total operating expenses
28,11 млн
22,58 млн
29,71 млн
24,83 млн
Operating income
8,21 млн
9,01 млн
11,03 млн
7,53 млн
Other non operating income
7,55 млн
11,82 млн
10,63 млн
94,25 мың
EBT including unusual items
15,69 млн
20,83 млн
20,85 млн
7,72 млн
EBT excluding unusual items
15,69 млн
20,83 млн
21,70 млн
7,72 млн
Income tax expense
1,99 млн
2,24 млн
2,39 млн
1,81 млн
Effective tax rate
12,67%
10,75%
11,48%
23,40%
Other operating expenses
-
-
-
-
Net income
13,70 млн
18,59 млн
18,46 млн
5,91 млн
Net profit margin
37,73%
58,86%
45,31%
18,27%
Earnings per share
-
-
-
-
Interest and investment income
4,92 мың
83,60 мың
114,79 м.
166,12 м.
Interest expense
-82,47 мың
-80,20 мың
-75,06 мың
-73,10 мың
Net interest expenses
-77,55 мың
3,40 мың
39,73 мың
93,01 мың
Depreciation and amortization charges
394,86 м.
388,14 м.
369,99 м.
367,76 м.
EBITDA
8,61 млн
9,40 млн
11,40 млн
7,90 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары